BioNTech's co-founder: Vaccine protects against UK and South Africa variants

In an unique interview with NCS, BioNTech co-founder and chief medical officer Özlem Türeci talks about receiving certainly one of Germany’s highest honors, the Order of Merit. She additionally discusses how her firm’s coronavirus vaccine is efficient against the UK variant and the South African variant.

Leave a Reply

Your email address will not be published. Required fields are marked *